1. Home
  2. PHVS vs TDUP Comparison

PHVS vs TDUP Comparison

Compare PHVS & TDUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • TDUP
  • Stock Information
  • Founded
  • PHVS 2015
  • TDUP 2009
  • Country
  • PHVS Switzerland
  • TDUP United States
  • Employees
  • PHVS N/A
  • TDUP N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • TDUP Catalog/Specialty Distribution
  • Sector
  • PHVS Health Care
  • TDUP Consumer Discretionary
  • Exchange
  • PHVS Nasdaq
  • TDUP Nasdaq
  • Market Cap
  • PHVS 1.6B
  • TDUP 1.3B
  • IPO Year
  • PHVS 2021
  • TDUP 2021
  • Fundamental
  • Price
  • PHVS $22.46
  • TDUP $8.51
  • Analyst Decision
  • PHVS Buy
  • TDUP Buy
  • Analyst Count
  • PHVS 6
  • TDUP 3
  • Target Price
  • PHVS $36.50
  • TDUP $12.50
  • AVG Volume (30 Days)
  • PHVS 217.3K
  • TDUP 1.5M
  • Earning Date
  • PHVS 11-12-2025
  • TDUP 11-03-2025
  • Dividend Yield
  • PHVS N/A
  • TDUP N/A
  • EPS Growth
  • PHVS N/A
  • TDUP N/A
  • EPS
  • PHVS N/A
  • TDUP N/A
  • Revenue
  • PHVS N/A
  • TDUP $277,729,000.00
  • Revenue This Year
  • PHVS N/A
  • TDUP $18.15
  • Revenue Next Year
  • PHVS N/A
  • TDUP $9.93
  • P/E Ratio
  • PHVS N/A
  • TDUP N/A
  • Revenue Growth
  • PHVS N/A
  • TDUP 20.14
  • 52 Week Low
  • PHVS $11.51
  • TDUP $0.50
  • 52 Week High
  • PHVS $26.33
  • TDUP $12.28
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 47.79
  • TDUP 39.58
  • Support Level
  • PHVS $21.99
  • TDUP $8.49
  • Resistance Level
  • PHVS $23.64
  • TDUP $9.45
  • Average True Range (ATR)
  • PHVS 1.28
  • TDUP 0.42
  • MACD
  • PHVS -0.01
  • TDUP -0.01
  • Stochastic Oscillator
  • PHVS 52.17
  • TDUP 23.33

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About TDUP ThredUp Inc.

ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.

Share on Social Networks: